These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32155809)

  • 21. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
    de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran.
    Ghanavati R; Ohadi E; Kazemian H; Yazdani F; Torki A; Kalani BS; Irajian G
    Recent Pat Antiinfect Drug Discov; 2018; 13(2):180-186. PubMed ID: 29769010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An insight into genes responsible for fosfomycin resistance among uropathogens of asymptomatic bacteriuria during pregnancy: A North Indian study.
    Khatoon S; Sultan A; Khan F; Khan T; Singh A
    Access Microbiol; 2023; 5(12):. PubMed ID: 38188241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
    Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
    Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
    Takahata S; Ida T; Hiraishi T; Sakakibara S; Maebashi K; Terada S; Muratani T; Matsumoto T; Nakahama C; Tomono K
    Int J Antimicrob Agents; 2010 Apr; 35(4):333-7. PubMed ID: 20071153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing
    Kawamura K; Hayashi K; Matsuo N; Kitaoka K; Kimura K; Wachino JI; Kondo T; Iinuma Y; Murakami N; Fujimoto S; Arakawa Y
    Microb Drug Resist; 2018 Dec; 24(10):1513-1520. PubMed ID: 29791251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in
    Sorlozano-Puerto A; Lopez-Machado I; Albertuz-Crespo M; Martinez-Gonzalez LJ; Gutierrez-Fernandez J
    Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32847131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular insights into fosfomycin resistance in Escherichia coli.
    Ballestero-Téllez M; Docobo-Pérez F; Portillo-Calderón I; Rodríguez-Martínez JM; Racero L; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2017 May; 72(5):1303-1309. PubMed ID: 28093485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence and characterisation of ESBL-encoding plasmids among Escherichia coli isolates from fresh vegetables.
    Freitag C; Michael GB; Li J; Kadlec K; Wang Y; Hassel M; Schwarz S
    Vet Microbiol; 2018 Jun; 219():63-69. PubMed ID: 29778206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.
    Keepers TR; Gomez M; Celeri C; Krause KM; Biek D; Critchley I
    Infect Dis Ther; 2017 Jun; 6(2):233-243. PubMed ID: 28285420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.
    Falagas ME; Kastoris AC; Kapaskelis AM; Karageorgopoulos DE
    Lancet Infect Dis; 2010 Jan; 10(1):43-50. PubMed ID: 20129148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study.
    Bielen L; Likić R; Erdeljić V; Mareković I; Firis N; Grgić-Medić M; Godan A; Tomić I; Hunjak B; Markotić A; Bejuk D; Tičić V; Balzar S; Bedenić B
    Croat Med J; 2018 Apr; 59(2):56-64. PubMed ID: 29740989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
    Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
    Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
    Hwang KP; Tang YF; Shen YH
    J Microbiol Immunol Infect; 2009 Oct; 42(5):433-8. PubMed ID: 20182674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.
    Ip M; Lai CK; Fung KSC; Wong KT; Zhu C; Van de Velde S; Tsang DN; Hawkey P
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2491-2494. PubMed ID: 28840351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.